EGFR and neoplasm: Previous authors synthesized cetuximab-decorated porphyrin-containing liposomal nanohybrid cerasomes (EGFR-CPIG), discovering that the EGFR-CPIG system accumulates preferentially at tumor locations and has a significant capacity for tumor targeting due to the combination of the EPR effect and the active tumor-targeting capability of EGFR [53].